Augmentation of cytotoxic drug action and X-irradiation by antibodies.

The effect of an antiserum containing antibodies against cell surface components of PyBHK cells on the action of certain anticancer agents has been studied using a colony formation inhibition assay. The effects of x-rays, chlorambucil, CCNU and possibly ICRF 159 are augmented by the antiserum wherea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubens, R. D., Vaughan-Smith, S., Dulbecco, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1975
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024752/
https://www.ncbi.nlm.nih.gov/pubmed/1233080
_version_ 1782136623470739456
author Rubens, R. D.
Vaughan-Smith, S.
Dulbecco, R.
author_facet Rubens, R. D.
Vaughan-Smith, S.
Dulbecco, R.
author_sort Rubens, R. D.
collection PubMed
description The effect of an antiserum containing antibodies against cell surface components of PyBHK cells on the action of certain anticancer agents has been studied using a colony formation inhibition assay. The effects of x-rays, chlorambucil, CCNU and possibly ICRF 159 are augmented by the antiserum whereas methotrexate and vinblastine are not.
format Text
id pubmed-2024752
institution National Center for Biotechnology Information
language English
publishDate 1975
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20247522009-09-10 Augmentation of cytotoxic drug action and X-irradiation by antibodies. Rubens, R. D. Vaughan-Smith, S. Dulbecco, R. Br J Cancer Research Article The effect of an antiserum containing antibodies against cell surface components of PyBHK cells on the action of certain anticancer agents has been studied using a colony formation inhibition assay. The effects of x-rays, chlorambucil, CCNU and possibly ICRF 159 are augmented by the antiserum whereas methotrexate and vinblastine are not. Nature Publishing Group 1975-09 /pmc/articles/PMC2024752/ /pubmed/1233080 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Rubens, R. D.
Vaughan-Smith, S.
Dulbecco, R.
Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title_full Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title_fullStr Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title_full_unstemmed Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title_short Augmentation of cytotoxic drug action and X-irradiation by antibodies.
title_sort augmentation of cytotoxic drug action and x-irradiation by antibodies.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024752/
https://www.ncbi.nlm.nih.gov/pubmed/1233080
work_keys_str_mv AT rubensrd augmentationofcytotoxicdrugactionandxirradiationbyantibodies
AT vaughansmiths augmentationofcytotoxicdrugactionandxirradiationbyantibodies
AT dulbeccor augmentationofcytotoxicdrugactionandxirradiationbyantibodies

Ejemplares similares